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were also found between the radiographic sub-groups for time taken to
complete the GAT. The median time to complete the test was longest
(29.4 seconds) for participants who had combined ﬁnger and thumb
OA, followed by thumb only (28.8) then ﬁnger only (26.6) and no OA
(26.3). Mean pinch and grip strength was stratiﬁed by gender, and only in
females were there signiﬁcant differences (grip p = 0.023, pinch p=0.001)
between the radiographic sub-groups with the combined group having
the lowest value (pinch=7.9lbs, grip = 33.7lbs) followed by the thumb
only OA group (pinch=8.8lbs, grip = 37.5lbs), the ﬁnger only OA group
(pinch=9.0lbs, grip = 38.3lbs). The no OA group had the highest mean
values (pinch=9.4lbs, grip = 39.8lbs).
Conclusions: Involvement of the thumb, with or without ﬁnger involve-
ment, is associated with more functional impairment, especially in women.
However, thumb OA involvement is not necessarily associated with more
pain.
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Purpose: The course and prognostic factors of hip osteoarthritis (OA)
are poorly investigated. Therefore the aim of this study is to describe the
course of pain and to analyze prognostic factors of progression of pain
and function in primary care patients with hip OA over 2 years.
Methods: This study was performed using data from 222 patients with
hip OA that were included in a randomized controlled trial over 2 years on
the effect of glucosamine sulfate. This trial found no difference between
glucosamine sulfate and placebo; we can therefore regard the data as
though it were from a cohort study.
General practitioners recruited prevalent hip OA patients. Patients were
included if they met one of the American College of Rheumatology criteria
for hip OA. One of the exclusion criteria was being on the waiting list for
a total hip arthroplasty.
We used the patients’ global assessment (PGA) of complaints (5 point
Likert scale; greatly improved to greatly deteriorated), a visual analogue
scale (VAS) for pain (0–100, 0 = no pain), and the Western Ontario
MacMaster Universities (WOMAC) pain and function (0–100, 0 = no pain)
as outcome measures. The PGA data was collected every 6 months, the
pain and function data was collected every 3 months following baseline.
The mean and the individual VAS pain data from all patients was plotted to
quantify the course of pain. The data for PGA of complaints was analyzed
using logistic regression analyses. The data for VAS pain and WOMAC
pain and function was ﬁrst logit transformed, then the difference between
the mean of the ﬁrst 3 and the mean of the last 3 measurements was
calculated and used as the outcome to compensate for the ﬂuctuations
with the individual patients. These difference scores were analyzed using
regression analyses to identify prognostic factors for progression of
hip OA symptoms. Patient characteristics, disease characteristics, and
measurements from a physical examination at baseline were used as
prognostic factors. Prognostic factors with a p< 0.2 that were identiﬁed
by univariate analysis were included in the multivariate analysis.
Results: On average the patients stayed relatively stable over time
(Figure 1).
On an individual level, patients showed large ﬂuctuations in pain scores
over time (Figures 2−4).
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A painful ﬂexion at baseline (OR 2.13 [95% CI 1.04; 4.37]) and a
Kellgren & Lawrence (K&L) score of 2 or more (OR 3.61 [95% CI 1.87;
6.95) were signiﬁcantly associated with progression of PGA of complaints
after 2 years.
We also found that age (b 0.02 [95% CI −0.00; 0.04]) and a K&L score
of 2 or more (b 0.42 [95%CI 0.04; 0.80) both contributed signiﬁcantly
to the progression of VAS pain over 2 years. For WOMAC pain and
function, none of the variables contributed signiﬁcantly to progression
in the multivariate analyses.
Conclusions: Our study showed that primary care patients with hip
OA on average had a stable level of pain, but that there is substantial
ﬂuctuation in pain level within patients over 2 years. It also shows that a
painful ﬂexion at baseline and a K&L of 2 or more leads to a deterioration
of complaints according to patients. Increasing age and a K&L of 2 or
more was associated with progression of pain over time.
